# Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®

> **NCT06904820** · — · RECRUITING · sponsor: **University Hospital, Limoges** · enrollment: 2300 (estimated)

## Conditions studied

- Viral Hepatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06904820
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-05
- **Primary completion:** 2035-06-05
- **Final completion:** 2035-06-05
- **Target enrollment:** 2300 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06904820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06904820, "Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06904820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
